HCA Stock Forecast 2025-2026
Distance to HCA Price Targets
HCA Price Momentum
🤔 Considering HCA Healthcare (HCA)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Latest HCA Stock Price Targets & Analyst Predictions
Based on our analysis of 40 Wall Street analysts, HCA has a bullish consensus with a median price target of $377.00 (ranging from $316.00 to $438.00). The overall analyst rating is Strong Buy (8.4/10). Currently trading at $319.39, the median forecast implies a 18.0% upside. This outlook is supported by 17 Buy, 7 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Andrew Mok at UBS, projecting a 37.1% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
HCA Analyst Ratings
HCA Price Target Range
Latest HCA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for HCA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 27, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $366.00 |
| Jan 27, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $384.00 |
| Jan 27, 2025 | B of A Securities | Kevin Fischbeck | Buy | Maintains | $370.00 |
| Jan 27, 2025 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $405.00 |
| Jan 7, 2025 | Keybanc | Tim Rezvan | Overweight | Maintains | $370.00 |
| Jan 6, 2025 | Truist Securities | David Macdonald | Buy | Maintains | $390.00 |
| Dec 17, 2024 | Morgan Stanley | Craig Hettenbach | Equal-Weight | Maintains | $355.00 |
| Dec 17, 2024 | JP Morgan | Benjamin Rossi | Neutral | Assumes | $380.00 |
| Nov 25, 2024 | Wells Fargo | Stephen Baxter | Underweight | Downgrade | $320.00 |
| Nov 22, 2024 | Raymond James | John Ransom | Market Perform | Downgrade | $0.00 |
| Nov 8, 2024 | Barclays | Andrew Mok | Overweight | Maintains | $392.00 |
| Nov 6, 2024 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $400.00 |
| Oct 28, 2024 | TD Cowen | Gary Taylor | Buy | Maintains | $440.00 |
| Oct 28, 2024 | Oppenheimer | Michael Wiederhorn | Outperform | Maintains | $400.00 |
| Oct 28, 2024 | Keybanc | Matthew Gillmor | Overweight | Maintains | $420.00 |
| Oct 22, 2024 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $395.00 |
| Oct 11, 2024 | Keybanc | Matthew Gillmor | Overweight | Initiates | $475.00 |
| Oct 4, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $392.00 |
| Oct 1, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $392.00 |
| Sep 3, 2024 | Morgan Stanley | Craig Hettenbach | Equal-Weight | Initiates | $427.00 |
HCA Healthcare Inc. (HCA) Competitors
The following stocks are similar to HCA Healthcare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
HCA Healthcare Inc. (HCA) Financial Data
HCA Healthcare Inc. has a market capitalization of $79.40B with a P/E ratio of 14.5x. The company generates $70.60B in trailing twelve-month revenue with a 8.2% profit margin.
Revenue growth is +5.7% quarter-over-quarter, while maintaining an operating margin of +15.6% and return on equity of +824.4%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
HCA Healthcare Inc. (HCA) Business Model
About HCA Healthcare Inc.
Operates healthcare facilities across the U.S.
The company generates revenue through a diverse range of healthcare services, including hospital care, outpatient services, and specialty treatments. By owning and operating a wide network of healthcare facilities, it captures various segments of patient care and drives profitability through high-quality medical services and strategic investments in technology.
HCA Healthcare is recognized for its commitment to clinical excellence and contributes to healthcare innovation through research and education initiatives. Its extensive reach across multiple states enhances healthcare accessibility and quality in both urban and rural areas, making it a significant player in the U.S. healthcare sector.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
226,000
CEO
Mr. Samuel N. Hazen
Country
United States
IPO Year
2011
Website
hcahealthcare.comHCA Healthcare Inc. (HCA) Latest News & Analysis
HCA Healthcare announced that 100 of its hospitals received the 2025 Patient Safety Excellence Award from Healthgrades, recognizing them as top 10% for patient-centered care and safety.
HCA Healthcare's recognition for patient safety enhances its reputation, potentially attracting more patients and improving financial performance, which positively impacts stock value.
17 Upcoming Dividend Increases
1 day agoA list of 17 companies shows upcoming dividend increases, with over 10% hikes and an average increase streak of 11 years, useful for investors focused on consistent dividends.
Upcoming dividend increases indicate financial health and commitment to returning value to shareholders, making these companies attractive for long-term investment strategies focused on income growth.
HCA Healthcare has been named one of the 2025 World's Most Ethical Companies by Ethisphere, marking its 15th recognition, and is one of three honorees in the Healthcare Providers category.
HCA Healthcare’s recognition as one of the World’s Most Ethical Companies enhances its reputation, potentially attracting more investors and customers, and may influence stock performance positively.
A tracker of 50 high-quality dividend stocks highlights 9 new attractively positioned stocks, providing 3 unique valuations for each based on historical free cash flow trends.
The identification of 9 attractively positioned dividend stocks with detailed valuations signals potential investment opportunities and informs strategic portfolio adjustments.
Zacks Premium offers Zacks Style Scores to help investors identify strong stocks, catering to value, growth, and momentum strategies.
The Zacks Style Scores can enhance stock-picking efficiency, potentially leading to better investment returns across various strategies, influencing investor decisions and market trends.
Miller-Howard Infrastructure Q4 2024 Commentary
17 days agoThe infrastructure portfolio was flat in Q4 but had its best year in three years, outperforming benchmarks. Over 80% of holdings increased dividends annually for the past five years.
Strong performance in infrastructure and rising dividends signal stability and growth potential, while sector shifts due to interest rates and AI trends impact investment strategies.
Frequently Asked Questions About HCA Stock
What is HCA Healthcare Inc.'s (HCA) stock forecast for 2025?
Based on our analysis of 40 Wall Street analysts, HCA Healthcare Inc. (HCA) has a median price target of $377.00. The highest price target is $438.00 and the lowest is $316.00.
Is HCA stock a good investment in 2025?
According to current analyst ratings, HCA has 17 Buy ratings, 7 Hold ratings, and 1 Sell ratings. The stock is currently trading at $319.39. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for HCA stock?
Wall Street analysts predict HCA stock could reach $377.00 in the next 12 months. This represents a 18.0% increase from the current price of $319.39. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is HCA Healthcare Inc.'s business model?
The company generates revenue through a diverse range of healthcare services, including hospital care, outpatient services, and specialty treatments. By owning and operating a wide network of healthcare facilities, it captures various segments of patient care and drives profitability through high-quality medical services and strategic investments in technology.
What is the highest forecasted price for HCA HCA Healthcare Inc.?
The highest price target for HCA is $438.00 from Andrew Mok at UBS, which represents a 37.1% increase from the current price of $319.39.
What is the lowest forecasted price for HCA HCA Healthcare Inc.?
The lowest price target for HCA is $316.00 from at , which represents a -1.1% decrease from the current price of $319.39.
What is the overall HCA consensus from analysts for HCA Healthcare Inc.?
The overall analyst consensus for HCA is bullish. Out of 40 Wall Street analysts, 17 rate it as Buy, 7 as Hold, and 1 as Sell, with a median price target of $377.00.
How accurate are HCA stock price projections?
Stock price projections, including those for HCA Healthcare Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
